col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: National Center for Biotechnology

14 Results       Page 1

 [1] 
  original article Journal Date Title Authors All Authors
1 [GO] Eurasian Journal of Applied Biotechnology 2024―Oct―29 INFLUENCE OF PHYSICOCHEMICAL FACTORS ON THE SARS-COV-2 STRAIN ISOLATED FROM A DOG S.O. Sadikaliyeva, E.Zh. Kalimolda, Zh.S. Abay, Ye.A. Shayakhmetov, S.U. Moldagulova, K.A. Shorayeva, et al. (+7)
2 [GO] Eurasian Journal of Applied Biotechnology 2024―Sep―18 SARS-COV-2 CORONAVIRUS ANTIGENS MODULATE THE ACTIVITY OF HUMAN T-REGULATORY CELLS S.A. Kan, A.V. Lushova, N. Abdolla, R. Tleulieva, Y.V. Perfilyeva, Y.O. Ostapchuk
3 [GO] Eurasian Journal of Applied Biotechnology 2024―Sep―18 ПРИМЕНЕНИЕ MALDI-TOF-MS И МАШИННОГО ОБУЧЕНИЯ ДЛЯ SARS-COV-2 И ДРУГИХ РЕСПИРАТОРНЫХ ИНФЕКЦИЙ И.А. Кадырова, А.А. Султанбекова
4 [GO] Eurasian Journal of Applied Biotechnology 2024―Sep―18 THE RECOMBINANT BACTERIA LACTOCOCCUS LACTIS EXPRESSING SARS-COV-2 SPIKE PROTEIN OR ITS RECEPTOR-BINDING DOMAIN ELICITS AN IMMUNE RESPONSE FOLLOWING ORAL IMMUNISATION OF RATS O.V. Evdokimova, A.E. Akhremchuk, L.N. Valentovich, O.E. Soboleva, S.V. Gubkin
5 [GO] Eurasian Journal of Applied Biotechnology 2024―Jul―05 Targeted in vitro- confirmation of the antiviral activity of Tenvir (Tenofovir) drug against the SARS-COV-2 virus variant B. in Kazakhstan and identifying NSP12 in the viral genome S. Khaidarov, Y. Burashev, N. Kozhabergenov, B. Usserbayev, A. Melisbek, M. Shirinbekov, et al. (+4)
6 [GO] Eurasian Journal of Applied Biotechnology 2024―Apr―04 SUPPRESSOR CELLS (MDSC) REGULATE THE T-CELL RESPONSE IN OLD MICE IMMUNIZED WITH THE WHOLE-VIRION SARS-CoV-2 VACCINE Y.V. Perfilyeva, N. Abdolla, A. Kali, R. Tleulieva, D. Aben, Y. Abdusattarova, et al. (+4)
7 [GO] Eurasian Journal of Applied Biotechnology 2023―Dec―28 STANDARTIZATION OF IMMUNOGENICITY OF INACTIVATED VACCINE QAZVAC AGAINST CORONAVIRUS INFECTION COVID-19 FROM AN EPIDEMIOLOGICALLY RELEVANT STRAIN B.Sh. Myrzakhmetova, G.A. Zhapparova, K.B. Bissenbayeva, A.S. Toytanova, M.S. Tuyskanova, G.D. Nakhanova, et al. (+3)
8 [GO] Eurasian Journal of Applied Biotechnology 2023―Oct―16 CO-INFECTION WITH COVID-19 AND GENETIC DIVERSITY OF SARS-COV-2 IN CHILDREN D. Kamalova, M. Makibayeva, A. Amirgazin, S. Abdrakhmanova, I. Sytnik, A. Tuleubaeva, et al. (+2)
9 [GO] Eurasian Journal of Applied Biotechnology 2023―Apr―13 POSSIBILITIES OF USING MEDICINES AND BIOLOGICALLY ACTIVE SUBSTANCES AS CORRECTIVES FOR THE FORMATION OF PULMONARY FIBROSIS DURING SARS-COV-2 INFECTION AND IN THE POST-COVID PERIOD Z.T. Shulgau, Y.K. Kamyshanskiy, A.Y. Gulyayev
10 [GO] Eurasian Journal of Applied Biotechnology 2023―Apr―13 BIOLOGICAL FEATURES OF THE SARS-COV-2 VIRUS FROM DOMESTIC ANIMALS IN THE TERRITORY OF THE RK S.O. Sadikalieva, E.A. Shayakhmetov, A.S. Nurpeisova, K.A. Shoraуeva, Zh.S. Abay, A.D. Omurtaу, et al. (+6)
11 [GO] Eurasian Journal of Applied Biotechnology 2022―Sep―16 INHIBITORY ACTIVITY OF ARTEMISIA ANNUA L. EXTRACTS AGAINST SARS-COV-2 CORONAVIRUS M. Zhurinov, A. Miftakhova, A. Shustov, V. Keyer, E. Solodova
12 [GO] Eurasian Journal of Applied Biotechnology 2022―Sep―16 THE PLANT ARTEMISIA ANNUA (“SWEET WORMWOOD”) KAZAKHSTAN’S SOURSE OF BIOACTIVE COMPOUNDS POTENTIALLY CURE THE SARS-CoV-2 INFECTION A. Maftakhova, L. Syzdykova, V. Keer, A. Shustov, M. Zhurinov
13 [GO] Eurasian Journal of Applied Biotechnology 2022―Jul―09 NUCLEOSIDE ANALOG FAVIPIRAVIR IS A POOR INHIBITOR AGAINST THE SARS-COV-2 VIRUS IN CELL CULTURE, BUT FAVIPIRAVIR IS HIGHLY ACTIVE AGAINST VENEZUELAN EQUINE ENCEPHALITIS VIRUS G.M. Zauatbayeva, L.R. Syzdykova, V.V. Keyer, A.V. Shustov, A.Z. Abilmagzhanov, M.Zh. Zhurynov
14 [GO] Eurasian Journal of Applied Biotechnology 2022―Jan―12 CRISPR/CAS12A-BASED DIAGNOSTICS FOR COVID-19 A. Kabylbayeva, K. Zharylgassynova, A. Abilova, M. Amanzholova, S. Abeldenov
 [1] 

14 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec